|
Quotes & Info
|
| GNBT > SEC Filings for GNBT > Form 8-K on 20-Oct-2009 | All Recent SEC Filings |
20-Oct-2009
Other Events, Financial Statements and Exhibits
Pursuant to Nasdaq Listing Rule 5250(b)(2), Generex Biotechnology Corporation (the "Company"), announced today that the Company's consolidated financial statements for the fiscal year ended July 31, 2009 included in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on October 14, 2009 contained a going concern qualification from its independent registered public accounting firm. A copy of the press release is attached as an exhibit to this report.
(d) Exhibits.
Exhibit
Number Description
99.1 Press Release issued by Generex Biotechnology
Corporation dated October 20, 2009.
|
|
|